Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Cambendazol is an antihelmintic that, at a dose of 50 mg/kg/day in mice, eradicates S. ratti adult worms from intestine and S. stercoralis larva from muscle.1 It inhibits polymerization of microtubules isolated from bovine brain with an IC50 value of 64.2 µM.2 Formulations containing cambendazol have been used to treat strongyloidiasis in humans and have been studied as potential chemotherapeutics.3,4
WARNING This product is not for human or veterinary use.
1. Strongyloides ratti and S. stercoralis: The effects of thiabendazole, mebendazole, and cambendazole in infected mice. Am. J. Trop. Med. Hyg. 31(3 Pt 1), 469-476 (1982).
2. Interaction of anthelmintic benzimidazoles and benzimidazole derivatives with bovine brain tubulin. Biochim. Biophys. Acta 544(3), 605-614 (1978).
3. Cambendazole in the treatment of human strongyloidiasis. Am. J. Trop. Med. Hyg. 32(5), 1181-1183 (1983).
4. Methods and compositions for the treatment of cancers and pathogenic infections. Patent Application Publication 1-7 (2010).